PDCD4 and breast carcinoma: In breast cancer, gastric cancer and ESCC, miR-183 is overexpressed, the overexpression significantly enhanced cell proliferation migration, invasion and inhibited cell apoptosis by targeting PDCD4 35, 36, 37, 38.